Sunset Bash on the Potomac: Shaping the Future of Global IP and Innovation

April 22, 2009

From patent reform, to an IP Czar, to a White House Chief Technology Officer, there is an increasing focus on the importance of IP and the need to obtain and enforce IP rights on a global basis. Striking the right balance for IP rights can positively impact the troubled economy.

Please join us for a reception with a diverse group of peers interested in shaping the future of global IP and innovation, and to welcome Jon Dudas, former Director of the USPTO. Enjoy exceptional conversation, food, drink, and phenomenal views of the Potomac.

Hal Wegner is the attorney responsible for the content of this program.

Authors

Harold C. Wegner

Practice Areas

Government Solutions
Intellectual Property
Chemical, Biotechnology & Pharmaceutical
Electronics
IP Litigation
Technology Transactions, Cybersecurity, and Privacy
Mechanical & Electromechanical Technologies
Trademark, Copyright & Advertising Counseling

Location

Foley & Lardner LLP
Sixth Floor Penthouse Conference Center
Historic Washington Harbour East
3000 K Street N.W.
Washington, D.C. 20007

Agenda

4:00 p.m. – 6:30 p.m.

People

Harold C. Wegner

Related Insights

View All Posts

June 3, 2025 Foley Corporate Governance Update

Texas Senate Bill 2337: Protecting Texas Companies and Their Directors, Shareholders and Boards from Proxy Advice Not in the Financial Interests of Shareholders

On June 2, 2025, the Texas Legislature passed Senate Bill 2337, meaningfully regulating proxy advisors like ISS and Glass Lewis when providing proxy voting recommendations concerning Texas companies.

September 25, 2025 Events

Unclaimed Property Roundtable with Delaware State Escheator and Leading Practitioners 

June 3, 2025 Health Care Law Today

GLP-1 Receptor Agonists: The Surge of M&A Activity and the Future of Metabolic Health

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for metabolic disorders, particularly type 2 diabetes and obesity.